Philadelphia consortium funds three companies developing pediatric devices

The hotel, which consists of 99 suites, was developed and owned by SMG Plymouth Meeting.
For the third year running, the Philadelphia Pediatric Medical Device Consortium is awarding grants to devicemakers developing products for children.

The Philadelphia Pediatric Medical Device Consortium is bankrolling a trio of startups developing an arm brace that boosts weak nerve signals, a rapid fluid-delivery system for emergencies and a device that corrects deformed ears in babies.

Cambridge, MA-based Myomo is working on a myoelectric arm orthosis to support a weak or deformed arm. The MyoPro orthosis uses sensors to detect electrical signals generated by muscle cells in the biceps and triceps in the upper arm and in the flexor and extensor muscle groups in the forearm, according to the company. When the user moves, these signals are amplified, driving small motors in the device that allow the user to perform movements, such as flexing and extending an elbow.

Meanwhile, Philadelphia-based EarGear uses silicon conformers to reshape infants’ ears, correcting a deformity over time. Its product would be an alternative to expensive and painful surgeries.


Join the world's top medtech executives virtually for the leading event in medtech — The Virtual MedTech Conference by AdvaMed

Expect the same high-quality education, world-class speakers and valuable business development in a virtual format. Experience more of the conference with on demand content and partnering, as well as livestreamed sessions.

Finally, Durham, NC’s 410 Medical is developing a hand-powered infuser that facilitates the rapid delivery of fluids to critically ill or injured patients. The device addresses problems with intravenous access and resistance to rapid flow that can dog physicians and responders trying to deliver fluids. The company is working on a second version of the device for the quick administration of blood products in patients who are hemorrhaging. It will use its grant to propel research supporting an FDA application for blood delivery.

Each company will receive $50,000 in funding from the consortium, which comprises the Children’s Hospital of Philadelphia, Drexel University and the University of Pennsylvania. This is the third year the consortium has awarded seed grants. Past recipients include Actuated Medical, which is working on a device to improve bone biopsies in children, and OtoNexus, which is developing a hand-held ultrasound device for the diagnosis of middle ear infections.

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.